COLESEVELAM ORAL SUSPENSION AS MONOTHERAPY OR ADD-ON TO METFORMIN THERAPY IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Lynch,Jane L

Funded by

DAIICHI PHARMACEUTICAL

Research Start Date

01/01/2017

Status

Inactive

Clinical Care

Drug Discovery

Diabetes and Obesity

Bioscience Research Panel